Feasibility of sending a direct send HPV self-sampling kit to long-term non-attenders in an organized cervical screening program

被引:4
|
作者
Sahlgren, Hanna [1 ,2 ]
Sparen, Par [1 ]
Elfgren, Kristina [3 ]
Elfstrom, K. Miriam [4 ,5 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[2] Reg Canc Ctr, Uppsala, Sweden
[3] Dept Clin Sci Intervent, Div Obstet & Gynecol, Stockholm, Sweden
[4] Karolinska Inst, Dept Lab Med, Stockholm, Sweden
[5] Karolinska Univ Hosp, Karolinska Univ Lab, Ctr Cerv Canc Prevent, Stockholm, Sweden
关键词
HPV; HPV self sampling; Cervical cancer; Cervical cancer screening; WOMEN; PARTICIPATION; TRIAL;
D O I
10.1016/j.ejogrb.2021.11.430
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: Non-participation in screening is a main risk factor for cervical cancer. Human-papillomavirus (HPV) self-sampling may be an alternative to repeated invitations for non-attenders. Several studies have concluded that participation among non-attenders increases significantly when offering self-sampling kits for HPV. However, participation rates are highly variable between settings, and therefore pilots to determine optimal implementation strategy have been recommended before routine roll out. Materials and Methods: All women who had not participated in the organized screening program for at least 10 years aged 33-62 in one Swedish county were identified through screening registers. HPV self-sampling kits were sent to all eligible women. Participation was defined as returning a self-sample kit or attending routine screening within 6 months. Women who did not submit the kit within 8 weeks were randomized to receive a written reminder. HPV-positive women were referred directly to colposcopy without prior triage. Biopsies for histopathologic confirmation were used as gold standard. Results: Among eligible women, 150/741 (20.2%) returned the self-sample kit or attended routine screening. A randomized written reminder was sent out to 319/591 non-responders and another 11 women returned the kit. In total, 23/147 (16.3%) of returned kits were HPV positive. Out of the 23 HPV-positive women, 17 (74%) attended colposcopy; 10/17 (59%) had a histopathological high-grade squamous intraepithelial lesions (HSIL) or cervical cancer. The most common HPV type was HPV 52, and 2 out of 3 women with HPV 16 had a histopathologically confirmed cancer. Conclusion: The direct send kit strategy and referral of all HPV-positive women to colposcopy without prior triage appears to be feasible if resources are available and should be prioritized given the high prevalence of HSIL lesions and cancer among non-attenders. A written reminder might further increase attendance. (C) 2021 The Authors. Published by Elsevier B.V.
引用
收藏
页码:68 / 73
页数:6
相关论文
共 43 条
  • [21] Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women
    Bosgraaf, Remko P.
    Ketelaars, Pleun J. W.
    Verhoef, Viola M. J.
    Massuger, Leon F. A. G.
    Meijer, Chris J. L. M.
    Melchers, Willem J. G.
    Bekkers, Ruud L. M.
    PREVENTIVE MEDICINE, 2014, 64 : 108 - 113
  • [22] Opportunistic offering of self-sampling to non-attenders within the English cervical screening programme: a pragmatic, multicentre, implementation feasibility trial with randomly allocated cluster intervention start dates (YouScreen)
    Lim, Anita W. W.
    Deats, Katie
    Gambell, Joanna
    Lawrence, Alexandra
    Lei, Jiayao
    Lyons, Mairead
    North, Bernard
    Parmar, Dharmishta
    Patel, Hasit
    Waller, Jo
    Warwick, Jane
    Sasieni, Peter D.
    ECLINICALMEDICINE, 2024, 73
  • [23] Experiences of Self-Sampling and Future Screening Preferences in Non-Attenders Who Returned an HPV Vaginal Self-Sample in the YouScreen Study: Findings From a Cross-Sectional Questionnaire
    Drysdale, Hannah
    Marlow, Laura A. V.
    Lim, Anita
    Waller, Jo
    HEALTH EXPECTATIONS, 2024, 27 (04)
  • [24] Offering Self-Sampling to Non-Attendees of Organized Primary HPV Screening: When Do Harms Outweigh the Benefits?
    Rozemeijer, Kirsten
    de Kok, Inge M. C. M.
    Naber, Steffie K.
    van Kemenade, Folkert J.
    Penning, Corine
    van Rosmalen, Joost
    van Ballegooijen, Marjolein
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (05) : 773 - 782
  • [25] Sociodemographic characteristics associated with cervical cancer screening participation by send-to-all and opt-in HPV self-sampling: Who benefits? Results from a randomized controlled trial among long-term non-attending women in Norway
    Hansen, Bo T.
    Nygard, Mari
    Castle, Phil E.
    Burger, Emily A.
    Aasbo, Gunvor
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (06) : 1053 - 1067
  • [26] Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program
    Tranberg, Mette
    Bech, Bodil Hammer
    Blaakaer, Jan
    Jensen, Jorgen Skov
    Svanholm, Hans
    Andersen, Berit
    BMC CANCER, 2016, 16
  • [27] Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme
    Bokan, Teodora
    Ivanus, Urska
    Jerman, Tine
    Takac, Iztok
    Arko, Darja
    RADIOLOGY AND ONCOLOGY, 2021, 55 (02) : 187 - 195
  • [28] Implementation of a self-sampling HPV test for non-responders to cervical cancer screening in Japan: secondary analysis of the ACCESS trial
    Fujita, Misuzu
    Nagashima, Kengo
    Shimazu, Minobu
    Suzuki, Misae
    Tauchi, Ichiro
    Sakuma, Miwa
    Yamamoto, Setsuko
    Hanaoka, Hideki
    Shozu, Makio
    Tsuruoka, Nobuhide
    Kasai, Tokuzo
    Hata, Akira
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [29] Feasibility and anticipated acceptability of community health worker-facilitated HPV self-sampling for cervical cancer screening around Lake County, Indiana
    Adekunle, Tiwaladeoluwa B.
    Arreola, Alyssa
    Sembian, Sathveka
    Castro, Raquel
    Claure, Layla
    Balian, Lara
    Rodriguez, Natalia M.
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 7 (01)
  • [30] Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program
    Mette Tranberg
    Bodil Hammer Bech
    Jan Blaakær
    Jørgen Skov Jensen
    Hans Svanholm
    Berit Andersen
    BMC Cancer, 16